






Originally published as: 
 
Thaa, B., Tielesch, C., Möller, L., Schmitt, A.O., Wolff, T., Bannert, N., Herrmann, A., Veit, M. 
Growth of influenza A virus is not impeded by simultaneous removal of the cholesterol-binding 
and acylation sites in the M2 protein 






This is an author manuscript that has been accepted for publication in Journal of General Virology, 
copyright Society for General Microbiology, but has not been copy-edited, formatted or proofed. Cite 
this article as appearing in Journal of General Virology. This version of the manuscript may not be 
duplicated or reproduced, other than for personal use or within the rule of ‘Fair Use of Copyrighted 
Materials’ (section 17, Title 17, US Code), without permission from the copyright owner, Society for 
General Microbiology. The Society for General Microbiology disclaims any responsibility or liability for 
errors or omissions in this version of the manuscript or in any version derived from it by any other 
parties. The final copy-edited, published article, which is the version of record, can be found at 

































Growth of influenza A virus is not impeded by simultaneous removal of the 
cholesterol binding and acylation sites in the M2 protein 
 
 
Bastian Thaa (1), Claudia Tielesch (1), Lars Möller (2), Armin O. Schmitt (3†), Thorsten Wolff (2), 




(1): Freie Universität Berlin, Faculty of Veterinary Medicine, Institute of Immunology and Molecular 
Biology, Philippstraße 13, 10115 Berlin, Germany 
(2): Robert Koch Institute, Nordufer 20, 13353 Berlin, Germany 
(3): Humboldt-Universität zu Berlin, Department for Crop and Animal Sciences, Invalidenstraße 42, 
10115 Berlin, Germany 
(4): Humboldt-Universität zu Berlin, Institute of Biology, Molecular Biophysics, Invalidenstraße 42, 
10115 Berlin, Germany 
 
 
Word count:  
Summary: 249 words, Text: 5479 words 
 







(†): present address: Faculty of Science and Technology, Free University of Bolzano/Bozen, 
Universitätsplatz 5/Piazza Università 5, 39100 Bozen/Bolzano, Italy 
(*): corresponding author: mveit@zedat.fu-berlin.de 
 
Summary 1 
Influenza virus assembly and budding occur in the “budozone”, a coalesced raft domain in the 2 
plasma membrane. The viral transmembrane protein M2 is implicated in virus particle scission, 3 
the ultimate step in virus budding, probably by wedge-like insertion of an amphiphilic helix into 4 
the membrane. In order to do so, M2 is hypothesised to be targeted to the edge of the budozone, 5 
mediated by acylation and cholesterol binding.  6 
We have recently shown that acylation and cholesterol binding affect membrane association of 7 
M2’s cytoplasmic tail and targeting of the protein to coalesced rafts. In this study, we tested 8 
whether the combined removal of the acylation site (C50) and the cholesterol-binding CRAC 9 
motifs (key residues Y52, Y57) in M2’s amphiphilic helix influence virus formation. 10 
We generated recombinant influenza viruses in the WSN background with mutations in one or 11 
both of these features. All these viruses showed, in comparison with the wildtype, very similar 12 
growth kinetics in various cell types. Wildtype and mutant viruses differed in their relative M2 13 
content, but not regarding the major structural proteins. The morphology of the viruses was not 14 
affected by mutating M2. Moreover, wildtype and mutant viruses showed comparable 15 
competitive fitness in infected cells. Lastly, a global comparison of M2 sequences revealed that 16 
there are natural virus strains with M2 devoid of both lipid-association motifs. Taken together, 17 
acylation and cholesterol-binding motifs in M2 are not crucial for replication of influenza virus 18 





Influenza A viruses are heteromorphous (spherical or filamentous), enveloped viruses in the 2 
family Orthomyxoviridae. Their membrane is lined from beneath by a matrix protein layer 3 
composed of the protein M1, which in turn envelopes the viral genome, arranged as eight viral 4 
ribonucleoprotein particles (vRNPs). The membrane contains three transmembrane proteins, 5 
the glycoproteins haemagglutinin (HA) and neuraminidase (NA) and the tetrameric proton 6 
channel protein M2. M2 (Fig. 1a) comprises 97 amino acid residues/monomer, with the N-7 
terminal 24 residues oriented towards the outside (ectodomain). The next 19 residues form a 8 
transmembrane domain assembled into a four-helix bundle that constitutes the proton channel. 9 
The residues 44–97 of M2 represent the cytoplasmic tail (M2-CT). Residues 48–62 form a 10 
membrane-parallel amphiphilic helix with a hydrophilic (solvent-exposed) and a hydrophobic 11 
(partially membrane-inserted) side. In addition, the M2-CT contains a binding site for M1 12 
(residues 71–73, (Chen et al., 2008)). 13 
In the infected cell, all these components are synthesised and ultimately transported to the 14 
apical plasma membrane for assembly and budding of progeny virions (Nayak  et al., 2009; 15 
Rossman & Lamb, 2011). Assembly is organised in “membrane rafts”, cholesterol- and 16 
sphingolipid-enriched nanodomains in the apical plasma membrane. These rafts are stabilized 17 
to form the “viral budozone” mainly by interactions among the viral components and with the 18 
raft lipids. The glycoproteins HA and NA have intrinsic raft-association features (Engel  et al., 19 
2010; Scheiffele et al., 1997; Scolari et al., 2009) and hence define the site of the budozone 20 
((Hess et al., 2005; Leser & Lamb, 2005), reviewed in (Veit & Thaa, 2011)). Conversely, the third 21 
transmembrane protein, M2, does not associate with typical raft markers (Leser & Lamb, 2005; 22 
Schroeder et al., 2005; Thaa et al., 2010; Zhang et al., 2000) and is, accordingly, mostly excluded 23 
from virions, although the protein is highly expressed at the infected cell’s surface (Lamb  et al., 24 
1985). Still, some of the M2 molecules need to reach the budozone for inclusion into virions. 25 
Targeting to the budozone might be achieved by the amphiphilic helix in the M2-CT, which 26 
comprises two potential raft-association features: (1) S-acylation (“palmitoylation”: covalent 27 
attachment of a saturated fatty acid, usually palmitic acid, by thioester linkage) at cysteine 28 
residue 50 (Sugrue et al., 1990; Veit et al., 1991), and (2) cholesterol binding (Schroeder et al., 29 
2005), most likely mediated by cholesterol recognition/interaction amino acid consensus 30 
(CRAC) motifs (L/V-X1–5-Y-X1–5-R/K), present up to four times in the amphiphilic helix region of 31 
the M2-CT depending on the virus strain. Schroeder et al. have hypothesised that M2 could 32 
accumulate at the edge of raft domains because the transmembrane domain is too short to be 33 
completely immersed in the highly-ordered raft phase and thus counteracts the raft-targeting 34 
features. Positioning of M2 at the raft edge could then entail the scission of virus particles: the 35 
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amphiphilic helix is assumed to induce curvature by wedge-like integration into the membrane 1 
(Schroeder et al., 2005). Indeed, there is experimental evidence that M2 plays an active role in 2 
scission. M2 accumulates at the neck of budding filamentous virions (the budozone edge), and 3 
M2 as well as a peptide encompassing the amphiphilic helix induce the formation of vesicles in 4 
giant unilamellar vesicles (GUVs), an in vitro membrane model system (Rossman et al., 2010a; 5 
Rossman et al., 2010b).  6 
We recently demonstrated that M2 intrinsically meets biochemical requirements of the 7 
Schroeder model: Mutation of tyrosines 52 and 57 (as part of overlapping CRAC motifs) 8 
abrogates cholesterol binding to M2-CT as purified protein. Furthermore, we showed that M2-9 
CT associates with membranes, both in vitro and in cells, and that the membrane-binding 10 
properties are modulated by exchange of the acylation site and the CRAC motif tyrosines.  11 
Furthermore, M2 has the propensity to partly associate with the coalesced raft phase in cell-12 
derived model membranes, dependent on acylation (Thaa et al., 2011). 13 
Here we have tested whether the same mutations in M2’s amphiphilic helix influence the growth 14 
properties of recombinant virus. Others have reported previously that mutations in either the 15 
acylation site or in the CRAC motifs of M2 do not significantly affect virus growth, at least in cell 16 
culture (Castrucci et al., 1997; Grantham et al., 2009; Rossman et al., 2010a; Stewart et al., 2010). 17 
However, the combined replacement of the two raft-association features in the amphiphilic helix 18 
of M2 has not been investigated so far in the context of the virus. Our hypothesis was that the 19 
combined elimination of both features would disconnect M2 from the budozone, leading to 20 
impeded virus budding. However, our results show that virus replication in cell culture is not 21 
markedly compromised by mutating one or both raft-targeting features in M2. This finding is 22 
discussed with focus on molecular interactions and functional redundancy of influenza virus 23 




Results  1 
Generation of recombinant virus and growth kinetics 2 
In Figure 1b, the amphiphilic helix of influenza A virus M2 is displayed as a “helical wheel plot”. 3 
This view along the helix axis shows the position of the individual amino acid residues; the helix 4 
is amphiphilic since charged/hydrophilic residues (dark grey) are clustered at one side of the 5 
helix and hydrophobic residues (light grey) at the other, directed towards the membrane. This 6 
has also been verified experimentally (Nguyen et al., 2008; Sharma et al., 2010). 7 
In previous studies, the acylation site cysteine 50 (see Fig. 1c, (Castrucci et al., 1997; Grantham 8 
et al., 2009)) or up to three residues in the CRAC motifs (Fig. 1d, (Stewart et al., 2010)) were 9 
replaced in the background of the strain Influenza A/WSN/33 (H1N1) as well as A/Udorn/72 10 
(H3N2), albeit without noticeable influence on viral replication in cell culture compared to the 11 
respective wildtype. Note that in the Udorn M2, the CRAC motif sequence consensus (L/V-X 1–5-Y-12 
X1–5-R/K) is not present. However, the protein associates with cholesterol (Rossman  et al., 13 
2010a), and the completion of the CRAC motif does not alter viral growth (Stewart  et al., 2010). 14 
To provoke a marked reduction in virus viability, five residues in the hydrophobic face of the 15 
amphiphilic helix had to be replaced in Udorn M2 (Fig. 1e (Rossman et al., 2010a; Rossman et 16 
al., 2010b)). However, none of these investigations examined the effects of a combined mutation 17 
of the acylation site and the CRAC motifs on influenza virus growth. 18 
To this end, we produced three different recombinant viruses encoding M2 mutations in the 19 
WSN background (see Fig. 1b): In the mutant WSN M2: Y52S, Y57S, the CRAC motifs were 20 
interrupted by replacing the two central tyrosine residues by serines, a mutation shown to 21 
abrogate cholesterol binding to purified M2-CT without changing the hydrophobicity pattern of 22 
the amphiphilic helix, and not to reduce acylation (Thaa et al., 2011). In WSN M2: C50S, the 23 
acylation site cysteine 50 was substituted by serine, and in the mutant WSN M2: C50S, Y52S, 24 
Y57S, the two features were disrupted simultaneously.  25 
All viruses could be rescued, as evidenced by plaque assay (Fig. 2a). Overall, the plaque size did 26 
not differ significantly between wildtype and mutants, implying that the mutants do not exhibit 27 
drastic growth defects. The mutant viruses could be passaged three times in Madin–Darby 28 
canine kidney (MDCK) cells without changes in the M2 sequence showing that the respective 29 
mutation was stable (data not shown). 30 
To analyse replication kinetics of the viruses, MDCK cells were infected with WSN wildtype or 31 
one of the mutants at a multiplicity of infection (MOI) of 0.01, supernatants were collected at 32 
various times and assessed for virus titre by plaque assay (Fig. 2b). The mutant with deleted 33 
acylation site reached identical titres as the wildtype virus confirming data by others for WSN as 34 
well as Udorn (Grantham et al., 2009). The mutant M2: Y52S, Y57S revealed reduced titres at 16 35 
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and 24 hours post-infection, albeit by less than one order of magnitude. Yet, this virus reached 1 
the same titres as wildtype at later times, showing that any possible delay in growth is not long-2 
lasting. This is in line with investigations where similar mutations in M2’s CRAC motifs did not 3 
perturb the growth of WSN either (Stewart et al., 2010). 4 
Surprisingly, the mutant lacking both the acylation site and the CRAC motifs (C50S, Y52S, Y57S) 5 
did not exhibit any reduction in titre at any time.  6 
We next analysed viral growth kinetics on cell types derived from the actual target organ of 7 
influenza virus, the respiratory tract. In the human alveolar epithelial adenocarcinoma cell line 8 
A549, the virus grew to titres that were generally lower compared to those in MDCK cells, but 9 
the growth kinetics were essentially identical for wildtype and mutant WSN (Fig. 2c). Likewise, 10 
all M2 mutant viruses also replicated comparingly to wildtype in non-transformed MRC-5 11 
human foetal lung fibroblasts (Jacobs et al., 1970) that can be regarded as primary cells (Fig. 12 
2d). Similarly to the situation in MDCK cells (Fig. 2b), there was a 10-fold reduction in virus titre 13 
for the M2: Y52S, Y57S mutant at intermediate (48 hours post-infection), but not at later times. 14 
The additional replacement of C50 did not intensify this effect as the mutant WSN M2: C50S, 15 
Y52S, Y57S grew identically as wildtype. Taken together, the mutation of the acylation site in 16 
combination with the CRAC motifs in M2 did not perturb replication of WSN in different cell 17 
systems. The mutant viruses characterised in this study may, however, be attenuated in animal 18 
hosts, e.g. mice. Indeed, such findings were reported both for viruses where the acylated 19 
cysteine in M2 was replaced (Grantham et al., 2009) and where the CRAC motifs were disrupted 20 
(Stewart et al., 2010).  21 
 22 
Electron microscopy 23 
Defects in budding and scission might be reflected by aberrant morphology of the resulting virus 24 
particles (Nayak et al., 2009). This was the case when five residues in the hydrophobic face of 25 
M2’s amphiphilic helix were replaced in the filamentous Udorn strain (Rossman  et al., 2010a). 26 
To examine whether acylation and/or the cholesterol-binding moiety of M2 have an influence on 27 
virion shape, particles were harvested from the supernatant of infected MDCK cells and 28 
visualised by negative-stain transmission electron microscopy. Fig. 3a shows that the virus 29 
particles were mostly spherical in all cases, yielding no evidence for any perturbation of virus 30 
morphology by mutations in M2. In addition, ultrathin sections of infected cells were produced 31 
and imaged by transmission electron microscopy. Defects in the last budding step (scission) 32 
would be reflected by a “beads-on-a-string” morphology of the budding virions, in which 33 
individual virions fail to be separated from each other (Nayak et al., 2009). Despite scrutinised 34 
inspection of samples, no such morphology was observed. The representative images in Fig. 3b 35 
show MDCK cells with WSN M2: Y52S, Y57S in the process of budding. This was the only mutant 36 
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that exhibited a slight reduction in titres (see Fig. 2b/d). Thus, WSN virus morphology is not 1 
altered by mutating the acylation site and/or the CRAC motifs in M2’s amphiphilic helix.   2 
Viral protein content 3 
We then assessed the content of the individual virus components in virus particles. If there was 4 
an influence of the raft-targeting motifs in M2 on the incorporation of viral proteins, there 5 
should be a difference in their relative abundance. However, the proportion of the major 6 
structural proteins, especially the ratio HA/M1, was the same in WSN wildtype and the mutants 7 
as illustrated with radioactively labelled virions by SDS-PAGE, fluorography and densitometric 8 
quantification (Fig 4a). This is in line with other reports investigating similar mutations 9 
(Grantham et al., 2009; Rossman et al., 2010a; Stewart et al., 2010). 10 
M2 cannot be discerned in the fluorograms in Fig. 4a since only minor amounts are 11 
incorporated into virions. Therefore, Western blot with an anti-M2 antibody was performed 12 
(Fig. 4b). The chemiluminescent signal intensity for M2 was related to that of M1 probed on the 13 
same membrane in parallel. M2 was detected as a double-band as noticed previously (Grantham  14 
et al., 2009; Zhirnov et al., 1999). In comparison to wildtype, WSN M2: Y52S, Y57S showed a 15 
significantly reduced M2/M1 ratio (i.e., less M2 incorporation). The mutant WSN M2: C50S, in 16 
contrast, contained more than twice the amount of M2 (normalised to M1) than wildtype. 17 
Interestingly, the virus in which both the cholesterol-association motifs and the acylation site 18 
were disrupted (WSN M2: C50S, Y52S, Y57S) did not display any marked change in the M2/M1 19 
ratio compared to wildtype. Thus, the opposing effects of CRAC and acylation site mutation on 20 
M2 integration into virions appear to compensate each other. 21 
Competition of wildtype and mutant virus 22 
We then hypothesised that mutating M2 might reduce the competitive fitness of the virus 23 
compared to wildtype. If one of the virus strains exhibits a selective advantage, it would rapidly 24 
eliminate the other. To test this, we co-infected MDCK cells with WSN wildtype and WSN M2: 25 
Y52S, Y57S (the mutant showing slight growth retardation) and analysed the cell culture 26 
supernatant after different times. The viral RNA in the supernatant was isolated, reverse-27 
transcribed into copy-DNA (cDNA), PCR-amplified and sequenced. Fig. 5a shows the sequencing 28 
chromatograms for the region of interest in the M2 gene in WSN wt and WSN M2: Y52S, Y57S 29 
(mut). When the supernatants of cells co-infected with wt and mut viruses (at a ratio of 1:1 or 30 
1:5; total MOI = 0.005) were analysed by sequencing, the two nucleotide species (wt and mut) 31 
were present in all cases, reflected by superimposed peaks for the respective bases (marked 32 
with arrows) in Fig. 5b (wt:mut = 1:1) and Fig. 5c (wt:mut = 1:5). Note that differences in peak 33 
heights and areas in the chromatograms should not be interpreted in a precise quantitative 34 
manner. Nevertheless, it is obvious that the mutant did not become “extinct” within the 35 
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timeframe of the experiment (96 hours). Competition experiments involving WSN wt and the 1 
other mutant viruses yielded the same result (data not shown).  2 
This is in contrast to recombinant viruses where the M2 proton channel is inactivated by the 3 
deletion of three amino acids in the transmembrane domain. In that case an analogous fitness 4 
assay revealed that wildtype virus almost completely overgrows the mutant virus within 5 
96 hours of co-cultivation even if the initial amount of wildtype is much lower (ratio wt:mut = 6 
1:100) (Takeda et al., 2002). Thus, our result demonstrates that there is no considerable 7 
decrease in viral fitness upon disruption of M2’s raft-targeting features.  8 
Conservation of acylation site and CRAC motifs in influenza A virus M2 protein 9 
Surprisingly, our combined experimental evidence argues against a synergistic role of M2’s 10 
acylation site C50 and the CRAC motif tyrosines for virus viability in cell culture. However, it has 11 
been noted that neither C50 (Sugrue et al., 1990; Veit et al., 1991) nor the CRAC motifs (e.g., in 12 
the Udorn strain) are strictly conserved in M2, implying that these features are not absolutely 13 
essential for virus replication. 14 
To find out whether there are also natural influenza virus strains in which both C50 and CRAC 15 
are absent (like in WSN M2: C50S, Y52S, Y57S), we analysed a total number of 18,477 influenza 16 
A M2 sequences retrieved from www.ncbi.nlm.nih.gov comprising at least 40 amino acids and 17 
containing residue 50. Multiple alignment of these sequences and bioinformatic data-mining 18 
revealed that a vast majority (84.0 %) of all deposited M2 sequences contain both a cysteine as 19 
residue 50 and at least one intact CRAC motif (see Table 1 for results). In 13.8 % of all 20 
sequences, CRAC is preserved, but C50 is replaced by another amino acid: Serine at position 50 21 
is observed mostly in human H1N1 strains; phenylalanine is present mainly in sequences of 22 
equine and canine H3N8 viruses, but also in human and chicken H5N1 strains; and tyrosine is 23 
found in bird strains, mainly of H6 subtype. Phenylalanine and tyrosine are bulky aromatic 24 
residues with relatively high hydrophobicity and membrane-insertion capacity. Thus they might 25 
at least partially compensate for the hydrophobicity of the wildtype S-acylated cysteine, 26 
contrary to serine with its hydrophilic hydroxyl group.  27 
1.9 % of all M2 sequences analysed possess C50 but no CRAC motif. These are mainly sequences 28 
from H3N2 viruses of human, porcine or avian origin, including the pandemic strain of the 1968 29 
outbreak (A/Aichi/2/68) and the filamentous laboratory strain Udorn. The M2 of these viruses 30 
might, however, still be capable of binding cholesterol, possibly with decreased affinity. The 31 
CRAC motif is defined rather loosely (L/V-X1–5-Y-X1–5-R/K) and probably depends on protein 32 
conformation rather than just the linear amino acid sequence (Schroeder, 2010). One of the two 33 
tyrosines demonstrated to be important for cholesterol association (Thaa  et al., 2011) is usually 34 
present in these strains. 35 
Lastly, a total number of 58 sequences (0.3 %) lack both the acylated cysteine at position 50 and 36 
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an intact CRAC motif. Of these, 12 sequences are artificial (sequences of M2 fragments for 1 
structural analysis), and the M2 sequence of one particular strain (A/Sendai/TU65/2006 2 
(H1N1)) was deposited at the database seven times. Notably, four of these strains carry a 3 
cysteine at position 52, which can be assumed to be a potential acylation site instead of the 4 
natural C50. Thus, there are 36 different, naturally occurring influenza A virus strains in the 5 
database whose M2 lack both acylation and cholesterol-binding motifs. This proves that such 6 
mutants indeed exist in nature. These strains are mostly human isolates from different 7 
geographic regions (Asia, Europe, America) typically isolated in 2000 or later and exclusively of 8 
subtype H1N1. It will be interesting to see whether new strains with these features will emerge; 9 
the result from our competition experiment (Fig. 5) is a hint that such mutants are not quickly 10 
competed out by wildtype. 11 
In summary, this global sequence comparison shows that the “standard” M2 protein contains 12 
both a palmitoylated cysteine at position 50 and at least one intact CRAC motif in the 13 






Our experimental data collectively show that the combined disruption of the acylation site and 2 
the CRAC motifs in M2’s amphiphilic helix has no effect on virus viability in cell culture although 3 
these features determine the membrane association capacity of the M2-CT and, in the case of 4 
acylation, also the partial association of M2 with coalesced rafts in giant plasma membrane 5 
vesicles, cell-derived model membranes (Thaa et al., 2011). Yet, an effect on incorporation of 6 
mutated M2 into virus particles was observed. Hence, we assume that targeting to the viral 7 
budozone was modified after disruption of CRAC and the acylation site, but did not result in 8 
diminished virus growth.   9 
Although cholesterol binding to the purified M2-CT (determined by crosslinking with [ 3H]-10 
photocholesterol) is drastically reduced upon mutation of the CRAC motif tyrosines (Thaa  et al., 11 
2011), we do not want to exclude that M2: Y52S, Y57S expressed during influenza virus infection 12 
has residual cholesterol binding activity that may be critical to virus growth. It can be imagined 13 
that M2’s transmembrane region contributes to cholesterol binding. Moreover, the cholesterol 14 
concentration in the plasma membrane and especially at the viral budozone might be high 15 
enough to allow association with even mutated M2. Technical limitations to label M2 and even 16 
the established cholesterol-binding protein caveolin ((Murata  et al., 1995) and data not shown) 17 
with [3H]-photocholesterol inside cells precluded our attempts to investigate this important 18 
issue further. Likewise, the methods we have used previously to examine raft-localisation of M2, 19 
namely FLIM-FRET (Thaa et al., 2010) and the preparation of giant plasma membrane vesicles 20 
(Thaa et al., 2011), cannot be performed in the context of virus-infected cells. 21 
Mutating C50 and/or CRAC in M2 did not impede virus replication. Yet we observed a reduced 22 
incorporation of M2 into virions upon CRAC disruption, which corresponded with a slight delay 23 
in virus replication. This might be due to a weaker interaction of the mutated M2 protein with 24 
the cholesterol-rich budozone. In contrast, replacement of C50 led to an increased proportion of 25 
M2 in the mature virions. The fatty acyl chains of palmitoylated proteins have been proposed to 26 
tilt transmembrane helices relative to the bilayer normal and hence reduce their effective length. 27 
Thus, lack of acylation might increase the interaction of M2 with raft domains (and hence the 28 
viral budozones), which are considered to be thicker than the bulk phase of the plasma 29 
membrane (Charollais & Van Der Goot, 2009; Morozova & Weiss, 2010). The virus in which both 30 
the cholesterol-association motifs and the acylation site were disrupted did not display any 31 
marked change in the M2/M1 ratio compared to wildtype. Hence, the opposing effects of CRAC 32 
and acylation site mutation on the incorporation of M2 into virus particles apparently 33 
compensate each other. Yet, the overall amount of M2 in mature virions is generally very low 34 
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(14–68 M2 molecules/virion), although the protein is abundantly expressed at the plasma 1 
membrane (Zebedee & Lamb, 1988). 2 
So far, only one mutation in M2’s amphiphilic helix has been described to lead to an impairment 3 
of virus growth in cells, namely the simultaneous replacement of five amino acids (F47, F48, I51, 4 
Y52, F55) in the hydrophobic face of the helix by less hydrophobic alanines ((Rossman  et al., 5 
2010a; Rossman et al., 2010b), see Fig. 1e). However, this set of mutations severely reduces the 6 
hydrophobic moment µH, a measure of the amphiphilicity of the helix (Eisenberg  et al., 1984). 7 
The µH value is reduced from 0.502 in the wildtype case to 0.244. Note however that the 8 
additional hydrophobicity of the cysteine-bound palmitate is not considered in this calculation.  9 
In contrast, all other mutations that were engineered in the amphiphilic helix of M2, in this study 10 
and those of others, do not markedly change the hydrophobic moment of the helix (listed in 11 
Table 2). Concomitantly, viruses carrying these mutations in their M2 show similar growth 12 
properties as wildtype. Thus, virus growth seems to depend rather on the amphiphilicity of the 13 
helix in the M2-CT than on the presence or absence of the two potential raft-targeting features, 14 
acylation and cholesterol association. We assume that the deepness of membrane insertion 15 
exerted by the amphiphilic helix determines whether M2 can fulfil its suggested role as mediator 16 
of virus particle scission. 17 
This conclusion is further backed by a new report, published during revision of this manuscript 18 
(Stewart & Pekosz, 2011). In that study, alanine scanning mutagenesis in M2’s amphiphilic helix 19 
did not markedly affect virus composition and viability, implying that this region tolerates 20 
numerous mutations and that the functionality of M2 for virus formation is based on the overall 21 
structure of the amphiphilic helix rather than its protein sequence. 22 
The targeting failures of mutant M2, which we have observed for individually expressed M2 23 
(Thaa et al., 2011), is probably compensated for by interactions of M2 in the context of infection. 24 
Most importantly, M2 binds to the viral matrix protein M1 via residues 71–73 in the M2-CT, 25 
which are not situated within the amphiphilic helix (Chen et al., 2008; McCown & Pekosz, 2006). 26 
M1 is assumed to organise virus assembly by interactions with the other viral components, 27 
including the cytoplasmic tails of raft-embedded HA and NA (Nayak  et al., 2009). M1 might thus 28 
drag M2 to the edge of the budozone, even if the intrinsic budozone-targeting features in M2 are 29 
disrupted. Accordingly, replacement of the acylation site and the CRAC motifs in M2 does not 30 
reduce virus viability in cells, but mutating the M1 binding site in M2 does (Chen  et al., 2008). 31 
It is the cooperative function of all the components that governs budozone organisation, virus 32 
assembly and budding. Our results, showing that virus growth is not affected by the mutation of 33 
the two lipid-interaction features in M2’s amphiphilic helix, reinforce the notion that these 34 





MDCK II (ATCC CRL-2936), HEK-293T (ATCC CRL-11268), A 549 (ATCC CCL-185) and MRC-5 3 
(ATCC CCL-171) cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, PAN 4 
Biotech) supplemented with 10 % foetal bovine serum (FBS, Perbio) at 37 °C, 5 % CO2, 95 % 5 
humidity, using standard techniques. 6 
Generation of recombinant virus 7 
Recombinant influenza A/WSN/33 (H1N1) virus was generated using the eight-plasmid reverse 8 
genetics system (Hoffmann et al., 2000), where each plasmid contains cDNA of one viral RNA 9 
segment, flanked by suitable promoters. In the M1-/M2-encoding cDNA segment 7, the codons 10 
for C50 (TGC) and/or Y52/Y57 (TAT/TAC) were replaced by serine codons (TCA, TCT and TCC, 11 
respectively), using QuikChange mutagenesis (Stratagene), and checked by sequencing (GATC). 12 
293T cells in 60-mm dishes were transfected with eight plasmids encoding WSN cDNA (1 µg 13 
each) using TurboFect (Fermentas/Thermo) in OptiMEM medium (Invitrogen). 4–6 h after 14 
transfection, medium was replaced by infection medium (DMEM + 0.2 % bovine serum albumin 15 
+ 0.1 % FBS + 2 mM glutamine + 1 µg/mL TPCK-treated trypsin (Sigma-Aldrich)) and incubation 16 
was continued at 37 °C. 48 h after transfection, supernatants were harvested and cleared of 17 
debris by low-speed centrifugation (2,000× g, 5 min, 4 °C). This supernatant was used to infect 18 
MDCK cells for virus propagation. After 1 h of adsorption, cells were washed with phosphate-19 
buffered saline (PBS), infection medium was supplied and incubation was continued until 20 
cytopathic effect became evident; then, the supernatant was harvested. 21 
Growth curve 22 
To assess growth kinetics, cells were infected with recombinant WSN at a multiplicity of 23 
infection (MOI) of 0.01. After 1 h of adsorption and washing with PBS, infection medium was 24 
supplied. The supernatant was harvested after a defined incubation time, cleared of debris and 25 
stored at −80 °C before titre determination by plaque assay.  26 
Plaque assay 27 
Plaque assay was performed on MDCK cells in 6-well plates according to standard procedures. 28 
Briefly, cells were infected with serial 10-fold dilutions of the virus supernatants in infection 29 
medium, incubated for 1 h at 37 °C, washed with PBS and overlayered with 0.9 % SeaKem 30 
agarose (Lonza) in Eagle’s minimum essential medium (EMEM) supplemented with 0.2 % 31 
bovine serum albumin, 0.1 % FBS, 2 mM glutamine, and 1 µg/mL TPCK-treated trypsin. After 3–32 
13 
 
4 days of incubation, cells were stained using neutral red (0.02 % in PBS, Biochrom), and 1 
plaques were counted. 2 
Reverse transcription (RT)-PCR and sequencing 3 
To check for correctness of M2 sequences in the recombinant viruses, RNA was isolated from 4 
cell culture supernatants with Invisorb Spin Virus RNA Mini Kit (Invitek) followed by reverse-5 
transcription and polymerase chain reaction (RT-PCR) using M2-specific primers and OneStep 6 
RT-PCR kit (Qiagen). PCR products were purified from agarose gels using the Fragment CleanUp 7 
Kit (Invitek) and sequenced (GATC). 8 
Radioactive labelling of viruses, SDS-PAGE and Western blot 9 
Radioactively labelled virus particles were produced by infecting MDCK cells in a 15-cm dish at 10 
MOI = 20. Three hours after infection, medium was replaced by DMEM lacking methionine, 11 
cysteine and glutamine, supplemented with 0.2 % bovine serum albumin, 0.1 % FBS, 5 mM 12 
glutamine, 1 µg/mL TPCK-treated trypsin and 0.3 µCi/mL [35S]-methionine/-cysteine (Tran35S-13 
Label, MP Biomedicals). 24 h after infection, supernatants were harvested, cell debris was 14 
removed (1,500× g, 10 min, 4 °C), and virus was pelleted from the supernatant by 15 
ultracentrifugation (Beckman SW-28 rotor, 28,000 rpm, 2 h, 4 °C), resuspended in 100 µL PBS 16 
and analysed by SDS-PAGE under reducing conditions and fluorography as described (Veit  et al., 17 
2008), or by SDS-PAGE followed by Western blot using the monoclonal anti-M2 antibody 14C2 18 
(Santa Cruz) and a polyclonal antiserum against fowl plague virus, which crossreacts with WSN-19 
M1, and horseradish peroxidase (HRP)-coupled secondary antibodies for chemiluminescence 20 
detection using ECL plus substrate (GE Healthcare) and a Fusion SL camera system (Promega), 21 
which detects photons over a wide linear signal-response range. Densitometric quantifications 22 
were done with Bio-1D software (Vilmer-Lourmat). 23 
Electron microscopy 24 
For negative staining, virus particles were pelleted from the supernatants of infected MDCK cells 25 
as described for radioactive labelling of viruses. In each case 4 µl of the resulting virus 26 
suspension were applied directly onto a carbon-coated, glow-discharged grid. After 10 min of 27 
incubation grids were washed three times with bidistilled water and stained with uranyl acetate 28 
(1 % in bidistilled water).  29 
For ultrathin sections, MDCK cells were infected at an MOI of 100, fixed 8 h post-infection with 30 
glutaraldehyde (2.5 % in 50 mM HEPES, pH 7.2) for 16 h at 4 °C and harvested by scraping. Cells 31 
were centrifuged (2,000× g, 5 min, 4 °C) and resuspended in 2.5 % glutaraldehyde buffer. After 32 
washing in 50 mM HEPES, pH 7.2, pellets were embedded in low melting-point agarose (3 % in 33 
bidistilled water, 1:1). Cells were post-fixed with osmium tetroxide (1 % in bidistilled water, 34 
14 
 
1 h), tannic acid (0.1 % in 50 mM HEPES, pH 7.2, 30 min) and uranyl  acetate (2 % in distilled 1 
water, 2 h), dehydrated stepwise in a graded ethanol series and embedded in epon resin. Thin 2 
sections (approx. 60 nm) were prepared with an ultramicrotome (Leica Ultracut  UCT), and 3 
counterstained with uranyl acetate (2 % in bidistilled water, 20 min.), followed by lead citrate 4 
(Reynolds solution, 3 min.). 5 
Negative stained samples and ultrathin sections  were examined using a JEM-2100 transmission 6 
electron microscope (JEOL) at 120 KV (negative staining) and 200 KV (ultrathin sections), 7 
respectively. Images were recorded using a Megaview III CCD  camera (Olympus SIS). 8 
Bioinformatics 9 
All Influenza A M2 sequences deposited at www.ncbi.nlm.nih.gov were downloaded on 5 May 10 
2011 in Fasta format and stored in one text file. 18,477 sequences with a length of at least 40 11 
amino acids and including residue 50 were considered for further analysis. The sequences were 12 
randomly split up into flat files containing 10,000 sequences each in order to speed up the 13 
generation of multiple sequence alignments using ClustalW (Thompson et al., 2002). The 14 
multiple alignments comprising 10,000 sequences were concatenated into one single Fasta 15 
sequence file and further processed with custom Perl scripts and Bioperl modules (Stajich et al., 16 
2002). The CRAC motif (L/V-X1–5-Y-X1–5-R/K) was extracted using Perl’s regular expression 17 
method.  18 
 19 
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Figure Legends 1 
 2 
Figure 1: (a) Topology sketch of M2, orientation of transmembrane domain and amphiphilic 3 
helix in the cytoplasmic tail according to NMR structural analysis (Sharma  et al., 2010). The 4 
acylation site (C50) and the tyrosines (Y52, Y57) in the cholesterol recognition/interaction 5 
amino acid consensus (CRAC) motifs are indicated. (b), helical wheel plot (axial view) of the 6 
amphiphilic helix (residues 46–61) of M2 from Influenza A/WSN/33 generated with Heliquest 7 
(heliquest.ipmc.cnrs.fr), orientation according to NMR structure (Sharma  et al., 2010). 8 
Hydrophobic residues in light grey, polar residues in dark grey. Arrows mark the residues 9 
substituted in this study. (c–e), helical wheel plot of M2’s amphiphilic helix indicating the 10 
residues changed in the studies of others (c: (Grantham et al., 2009), d: (Stewart et al., 2010), e: 11 
(Rossman et al., 2010a)), virus strain: WSN (c, d)/Udorn (e, amino acid differences compared 12 
with WSN labelled in italics). See text for details. 13 
 14 
Figure 2: Growth of recombinant influenza viruses (WSN strain) with mutations in M2. (a), 15 
representative plaque assays of WSN wildtype (top left) and carrying the indicated mutations. 16 
(b–d), growth curves. MDCK II (b), A549 (c) or MRC-5 (d) cells were infected with the indicated 17 
virus at MOI = 0.01, cell culture supernatants were harvested after the indicated times and 18 
tested for infectious titres by plaque assay. The experiments were done in triplicate and are 19 
displayed as mean ± standard deviation. The titre reduction of WSN M2: Y52S, Y57S was 20 
observed in each experiment. Non-discernible error bars are smaller than the respective data 21 
point symbol.  22 
 23 
Figure 3: Characterisation of WSN wildtype and mutants thereof by transmission electron 24 
microscopy. (a), representative negative stain images of the indicated virus harvested from the 25 
supernatant of infected MDCK cells. Scale bar, 200 nm. (b), representative ultrathin sections of 26 
MDCK cells infected with WSN M2: Y52S, Y57S. Scale bar, 200 nm. 27 
 28 
Figure 4: Determination of viral protein content. (a), Radioactively labelled WSN (wildtype and 29 
indicated mutants) were generated by infection of MDCK cells in the presence of [35S]-30 
methionine/-cysteine, pelleted from the cell culture supernatant and subjected to SDS-PAGE and 31 
fluorography. Band intensities from this and three other experiments were quantified by 32 
densitometry on scanned films. The mean HA/M1 ratios (normalised to wildtype) are displayed 33 
below each lane. (b), M2 and M1 were detected by Western blot. The indicated mean M2 content 34 
in the viruses (relative to M1, normalised to wildtype) was determined from three experiments. 35 
19 
 
The position of the viral proteins is indicated on the right-hand side, molecular weight marker 1 
(kDa) on the left-hand side.  2 
 3 
Figure 5: Competitive growth of WSN wildtype and WSN mutant M2: Y52S, Y57S. (a), 4 
sequencing chromatograms of copy-DNA of WSN wt (left-hand side) and WSN mut (right-hand 5 
side). (b and c), 2.4×106 MDCK cells were infected with 12,000 plaque-forming units (pfu) of 6 
WSN wt and mut at a ratio of 1:1 (b) or 1:5 (c), supernatants were collected at the indicated 7 
times post-infection, viral RNA was isolated, subjected to RT-PCR and sequenced. Nucleotide 8 












































Table 1: Numbers of influenza A M2 sequences retrieved from www.ncbi.nlm.nih.gov, grouped 4 











wt LFFKCIYRRFKYGLKR + 0.422   
R54F LFFKCIYRFFKYGLKR + 0.492  * 
L46A, Y52A, R54A AFFKCIARAFKYGLKR – 0.523  * 
C50S LFFKSIYRRFKYGLKR + 0.475  †, § 
Y52S, Y57S LFFKCISRRFKSGLKR – 0.461  § 
C50S, Y52S, Y57S LFFKSISRRFKSGLKR – 0.510  § 
Udorn strain 
wt LFFKCIYRFFEHGLKR – 0.502   
F54R LFFKCIYRRFEHGLKR + 0.451  * 
C50S LFFKSIYRFFEHGLKR – 0.533  †, ‡ 
F47A LAFKCIYRFFEHGLKR – 0.439  ‡ 
F48A LFAKCIYRFFEHGLKR – 0.457  ‡ 
I51A LFFKCAYRFFEHGLKR – 0.409  ‡ 
Y52A LFFKCIARFFEHGLKR – 0.508  ‡ 
F55A LFFKCIYRFAEHGLKR – 0.431  ‡ 
F47A, F48A, I51A, 
Y52A, F55A 
LAAKCAARFAEHGLKR – 0.244 yes ‡ 
 8 
Table 2: Amphiphilicity of the helix formed by residues 46–61 in the cytoplasmic tail of M2 and 9 
different mutants thereof, studied in the context of the virus in this study and the indicated 10 
references. The hydrophobic moment µH is displayed as calculated with heliquest.ipmc.cnrs.fr. 11 
The presence or absence of CRAC motifs is indicated. References: *, (Stewart  et al., 2010); †, 12 
(Grantham et al., 2009); ‡, (Rossman et al., 2010a), §, this work. 13 
 14 





